MOMENTA PHARMACEUTICALS INC's ticker is MNTA and the CUSIP is 60877T100. A total of 149 filers reported holding MOMENTA PHARMACEUTICALS INC in Q4 2014. The put-call ratio across all filers is 0.33 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $2,010,000 | -5.7% | 108,643 | -13.8% | 0.01% | -11.1% |
| Q2 2017 | $2,131,000 | +41.6% | 126,094 | +11.9% | 0.01% | +50.0% |
| Q1 2017 | $1,505,000 | +147.9% | 112,712 | +179.3% | 0.01% | +100.0% |
| Q4 2016 | $607,000 | +22.6% | 40,351 | -4.7% | 0.00% | +50.0% |
| Q3 2016 | $495,000 | +8.3% | 42,338 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $457,000 | +25.9% | 42,338 | +7.7% | 0.00% | 0.0% |
| Q1 2016 | $363,000 | -51.0% | 39,308 | -21.3% | 0.00% | -33.3% |
| Q4 2015 | $741,000 | -8.0% | 49,941 | +1.8% | 0.00% | -25.0% |
| Q3 2015 | $805,000 | -28.1% | 49,056 | 0.0% | 0.00% | -20.0% |
| Q2 2015 | $1,119,000 | +45.3% | 49,056 | -3.2% | 0.01% | +66.7% |
| Q1 2015 | $770,000 | +36.3% | 50,654 | +8.0% | 0.00% | +50.0% |
| Q4 2014 | $565,000 | +18.7% | 46,921 | +11.7% | 0.00% | 0.0% |
| Q3 2014 | $476,000 | -6.7% | 42,011 | -0.4% | 0.00% | 0.0% |
| Q2 2014 | $510,000 | +5.2% | 42,192 | +1.3% | 0.00% | 0.0% |
| Q1 2014 | $485,000 | -33.8% | 41,633 | +0.4% | 0.00% | -33.3% |
| Q4 2013 | $733,000 | +19.6% | 41,481 | -2.6% | 0.00% | 0.0% |
| Q3 2013 | $613,000 | +14.2% | 42,598 | +19.5% | 0.00% | 0.0% |
| Q2 2013 | $537,000 | – | 35,632 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 450,000 | $7,605,000 | 3.18% |
| ARMISTICE CAPITAL, LLC | 820,000 | $13,858,000 | 1.77% |
| Marcus Capital, LLC | 104,000 | $1,758,000 | 1.50% |
| SECTOR GAMMA AS | 605,545 | $10,234,000 | 1.49% |
| Palo Alto Investors LP | 1,787,576 | $30,210,000 | 1.41% |
| SECTORAL ASSET MANAGEMENT INC | 299,400 | $5,060,000 | 0.55% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 433,060 | $7,318,000 | 0.53% |
| DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 1,232,929 | $20,837,000 | 0.51% |
| Orbimed Advisors | 2,109,068 | $35,643,000 | 0.37% |
| TFS CAPITAL LLC | 52,290 | $884,000 | 0.35% |